| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 MEGF6 MEGF8 SYT8 PAMR1 LRP1 LTBP2 CUBN PKD1L2 REPS2 LTBP4 LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 6.11e-09 | 749 | 71 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.41e-07 | 188 | 71 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.79e-05 | 44 | 71 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.70e-05 | 20 | 71 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.01e-04 | 68 | 71 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.07e-04 | 69 | 71 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | Notch binding | 1.19e-04 | 27 | 71 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.19e-04 | 71 | 71 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.64e-04 | 229 | 71 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | nodal binding | 3.44e-04 | 8 | 71 | 2 | GO:0038100 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 3.44e-04 | 8 | 71 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 4.98e-04 | 103 | 71 | 4 | GO:0008276 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 5.35e-04 | 105 | 71 | 4 | GO:0008170 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 5.51e-04 | 10 | 71 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | transcription regulator activator activity | 5.51e-04 | 10 | 71 | 2 | GO:0140537 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 8.04e-04 | 12 | 71 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 9.48e-04 | 13 | 71 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | activin receptor binding | 1.10e-03 | 14 | 71 | 2 | GO:0070697 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.45e-03 | 16 | 71 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | clathrin binding | 1.47e-03 | 63 | 71 | 3 | GO:0030276 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.51e-03 | 21 | 71 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 3.30e-03 | 172 | 71 | 4 | GO:0008757 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 3.45e-03 | 85 | 71 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.78e-03 | 562 | 71 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase binding | 4.13e-03 | 27 | 71 | 2 | GO:0070696 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 5.85e-07 | 92 | 68 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | blood vessel development | NRXN3 MEGF8 CFC1 CD40 LRP1 LAMA4 LRP5 CFC1B VEGFD LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.63e-06 | 929 | 68 | 14 | GO:0001568 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | TGFB1I1 MEGF8 LPXN CFC1 LRP1 CFC1B LTBP2 LTBP4 NOTCH1 NOTCH2 | 1.88e-06 | 445 | 68 | 10 | GO:0141091 |
| GeneOntologyBiologicalProcess | vasculature development | NRXN3 MEGF8 CFC1 CD40 LRP1 LAMA4 LRP5 CFC1B VEGFD LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 2.67e-06 | 969 | 68 | 14 | GO:0001944 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | TGFB1I1 MEGF8 LPXN CFC1 LRP1 CFC1B LTBP2 LTBP4 NOTCH1 NOTCH2 | 3.82e-06 | 482 | 68 | 10 | GO:0007178 |
| GeneOntologyBiologicalProcess | axon guidance | 4.34e-06 | 285 | 68 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.46e-06 | 286 | 68 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 4.53e-06 | 74 | 68 | 5 | GO:0042733 | |
| GeneOntologyBiologicalProcess | artery development | 5.06e-06 | 133 | 68 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 5.24e-06 | 35 | 68 | 4 | GO:0003209 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 5.29e-06 | 134 | 68 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | determination of heart left/right asymmetry | 6.26e-06 | 79 | 68 | 5 | GO:0061371 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 6.66e-06 | 80 | 68 | 5 | GO:0003143 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 7.98e-06 | 83 | 68 | 5 | GO:0060976 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 9.36e-06 | 148 | 68 | 6 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 9.36e-06 | 148 | 68 | 6 | GO:0035113 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 1.10e-05 | 42 | 68 | 4 | GO:0003230 | |
| GeneOntologyBiologicalProcess | embryo development | TGFB1I1 JAG2 KMT2D ZBTB16 SALL1 MEGF8 CFC1 NSD1 LAMA2 LAMA3 LAMA4 LRP5 CFC1B CUBN NOTCH1 NOTCH2 | 1.31e-05 | 1437 | 68 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | tube morphogenesis | NRXN3 SALL1 MEGF8 CFC1 CD40 LRP1 LRP5 CFC1B VEGFD LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.47e-05 | 1125 | 68 | 14 | GO:0035239 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | TGFB1I1 JAG2 ZBTB16 SALL1 MEGF8 CFC1 NSD1 LRP5 CFC1B NOTCH1 NOTCH2 | 1.99e-05 | 713 | 68 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | cell fate determination | 2.22e-05 | 50 | 68 | 4 | GO:0001709 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 2.29e-05 | 103 | 68 | 5 | GO:0035050 | |
| GeneOntologyBiologicalProcess | atrial septum morphogenesis | 2.70e-05 | 18 | 68 | 3 | GO:0060413 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 3.21e-05 | 3 | 68 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.31e-05 | 185 | 68 | 6 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.31e-05 | 185 | 68 | 6 | GO:0035108 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | TGFB1I1 JAG2 SALL1 MEGF8 CFC1 LRP5 CFC1B NOTCH1 NOTCH2 NOTCH4 | 3.34e-05 | 619 | 68 | 10 | GO:0002009 |
| GeneOntologyBiologicalProcess | circulatory system development | NRXN3 SALL1 MEGF8 CFC1 CD40 LRP1 LAMA4 LRP5 CFC1B VEGFD LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.65e-05 | 1442 | 68 | 15 | GO:0072359 |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 6.40e-05 | 4 | 68 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | left lung morphogenesis | 6.40e-05 | 4 | 68 | 2 | GO:0060460 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | NRXN3 MEGF8 CD40 LRP1 LRP5 VEGFD LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 6.85e-05 | 817 | 68 | 11 | GO:0048514 |
| GeneOntologyBiologicalProcess | cardiac chamber development | 7.07e-05 | 212 | 68 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 7.14e-05 | 421 | 68 | 8 | GO:0060562 | |
| GeneOntologyBiologicalProcess | atrial septum development | 7.48e-05 | 25 | 68 | 3 | GO:0003283 | |
| GeneOntologyBiologicalProcess | limb development | 9.58e-05 | 224 | 68 | 6 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 9.58e-05 | 224 | 68 | 6 | GO:0048736 | |
| GeneOntologyBiologicalProcess | heart looping | 9.91e-05 | 73 | 68 | 4 | GO:0001947 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 1.06e-04 | 28 | 68 | 3 | GO:0051152 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.06e-04 | 5 | 68 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | left lung development | 1.06e-04 | 5 | 68 | 2 | GO:0060459 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | TGFB1I1 MEGF8 LPXN CFC1 LRP1 CFC1B LTBP2 REPS2 VEGFD LTBP4 TNXB NOTCH1 NOTCH2 | 1.14e-04 | 1186 | 68 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.23e-04 | 338 | 68 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 1.31e-04 | 30 | 68 | 3 | GO:0072012 | |
| GeneOntologyBiologicalProcess | aorta development | 1.41e-04 | 80 | 68 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 1.44e-04 | 31 | 68 | 3 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 1.44e-04 | 31 | 68 | 3 | GO:0061437 | |
| GeneOntologyBiologicalProcess | digestive tract development | 1.46e-04 | 152 | 68 | 5 | GO:0048565 | |
| GeneOntologyBiologicalProcess | determination of left/right symmetry | 1.55e-04 | 154 | 68 | 5 | GO:0007368 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in morphogenesis | 1.59e-04 | 32 | 68 | 3 | GO:0060561 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 1.59e-04 | 6 | 68 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 1.59e-04 | 6 | 68 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 1.59e-04 | 6 | 68 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 1.59e-04 | 6 | 68 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 1.59e-04 | 6 | 68 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | tube development | NRXN3 SALL1 MEGF8 CFC1 CD40 LRP1 LRP5 CFC1B VEGFD LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.61e-04 | 1402 | 68 | 14 | GO:0035295 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | TGFB1I1 JAG2 SALL1 MEGF8 CFC1 LRP5 CFC1B NOTCH1 NOTCH2 NOTCH4 | 1.64e-04 | 750 | 68 | 10 | GO:0048729 |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 1.71e-04 | 84 | 68 | 4 | GO:1903053 | |
| GeneOntologyBiologicalProcess | left/right pattern formation | 1.96e-04 | 162 | 68 | 5 | GO:0060972 | |
| GeneOntologyBiologicalProcess | gastrulation with mouth forming second | 2.08e-04 | 35 | 68 | 3 | GO:0001702 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 2.14e-04 | 89 | 68 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | determination of bilateral symmetry | 2.14e-04 | 165 | 68 | 5 | GO:0009855 | |
| GeneOntologyBiologicalProcess | specification of symmetry | 2.14e-04 | 165 | 68 | 5 | GO:0009799 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 2.23e-04 | 7 | 68 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 2.23e-04 | 7 | 68 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 2.23e-04 | 7 | 68 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 2.23e-04 | 7 | 68 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | digestive system development | 2.26e-04 | 167 | 68 | 5 | GO:0055123 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 2.96e-04 | 8 | 68 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | TGFB1I1 ZBTB16 SALL1 MEGF8 INSM1 LRP1 LAMA2 LRP5 TNXB NOTCH1 NOTCH2 NOTCH4 | 3.18e-04 | 1141 | 68 | 12 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 3.21e-04 | 99 | 68 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 3.34e-04 | 41 | 68 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 3.80e-04 | 9 | 68 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 3.80e-04 | 9 | 68 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 4.10e-04 | 412 | 68 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 4.17e-04 | 106 | 68 | 4 | GO:0051149 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | TGFB1I1 MEGF8 LPXN LRP1 LTBP2 VEGFD LTBP4 TNXB NOTCH1 NOTCH2 | 4.46e-04 | 850 | 68 | 10 | GO:0071363 |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 4.74e-04 | 10 | 68 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 5.01e-04 | 47 | 68 | 3 | GO:1902742 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 5.01e-04 | 47 | 68 | 3 | GO:0035850 | |
| GeneOntologyBiologicalProcess | axonogenesis | 5.32e-04 | 566 | 68 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 5.66e-04 | 49 | 68 | 3 | GO:0035137 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 5.78e-04 | 11 | 68 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | elastic fiber assembly | 5.78e-04 | 11 | 68 | 2 | GO:0048251 | |
| GeneOntologyBiologicalProcess | response to growth factor | TGFB1I1 MEGF8 LPXN LRP1 LTBP2 VEGFD LTBP4 TNXB NOTCH1 NOTCH2 | 6.00e-04 | 883 | 68 | 10 | GO:0070848 |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 6.46e-04 | 210 | 68 | 5 | GO:0007219 | |
| GeneOntologyBiologicalProcess | gastrulation | 6.74e-04 | 212 | 68 | 5 | GO:0007369 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 6.92e-04 | 12 | 68 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell differentiation | 7.54e-04 | 54 | 68 | 3 | GO:0051150 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 7.95e-04 | 55 | 68 | 3 | GO:0140718 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 8.16e-04 | 13 | 68 | 2 | GO:0048845 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 8.73e-04 | 927 | 68 | 10 | GO:0030155 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 8.83e-04 | 57 | 68 | 3 | GO:0061005 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 9.50e-04 | 14 | 68 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 9.50e-04 | 14 | 68 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 9.76e-04 | 59 | 68 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 9.76e-04 | 59 | 68 | 3 | GO:0048546 | |
| GeneOntologyBiologicalProcess | regionalization | 9.84e-04 | 478 | 68 | 7 | GO:0003002 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.03e-03 | 135 | 68 | 4 | GO:2000177 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle clearance | 1.09e-03 | 15 | 68 | 2 | GO:0010989 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial to mesenchymal transition | 1.18e-03 | 63 | 68 | 3 | GO:0010718 | |
| GeneOntologyCellularComponent | extracellular matrix | TGFB1I1 MEGF6 LAMA2 LAMA3 LAMA4 LTBP2 LTBP4 SSPOP MUC5AC TNXB | 7.11e-05 | 656 | 71 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | TGFB1I1 MEGF6 LAMA2 LAMA3 LAMA4 LTBP2 LTBP4 SSPOP MUC5AC TNXB | 7.29e-05 | 658 | 71 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 7.45e-05 | 530 | 71 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | receptor complex | 1.49e-04 | 581 | 71 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | cell surface | LY6G5B TNFRSF9 CFC1 CD40 LRP1 CFC1B CUBN LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 3.35e-04 | 1111 | 71 | 12 | GO:0009986 |
| HumanPheno | Abnormal blood vessel morphology | KMT2D ZBTB16 SALL1 KMT2B MEGF8 CFC1 NSD1 LAMA2 LAMA4 LRP5 CASP10 LTBP2 LTBP4 TNXB LDLR NOTCH1 NOTCH2 NOTCH3 | 1.03e-05 | 1201 | 29 | 18 | HP:0033353 |
| MousePheno | accessory spleen | 5.31e-06 | 9 | 57 | 3 | MP:0003342 | |
| MousePheno | total anomalous pulmonary venous connection, intracardiac | 1.63e-05 | 2 | 57 | 2 | MP:0010443 | |
| MousePheno | d-loop transposition of the great arteries | 1.79e-05 | 13 | 57 | 3 | MP:0011665 | |
| MousePheno | abnormal direction of embryo turning | 1.79e-05 | 13 | 57 | 3 | MP:0004190 | |
| MousePheno | anomalous pulmonary venous connection | 2.82e-05 | 15 | 57 | 3 | MP:0010440 | |
| MousePheno | mesocardia | 6.98e-05 | 20 | 57 | 3 | MP:0000650 | |
| MousePheno | unbalanced complete common atrioventricular canal | 9.75e-05 | 4 | 57 | 2 | MP:0011673 | |
| MousePheno | total anomalous pulmonary venous connection | 9.75e-05 | 4 | 57 | 2 | MP:0010441 | |
| MousePheno | right pulmonary isomerism | 1.39e-04 | 25 | 57 | 3 | MP:0000531 | |
| MousePheno | complete atrioventricular septal defect | 1.56e-04 | 26 | 57 | 3 | MP:0010413 | |
| MousePheno | abnormal axon radial sorting | 1.62e-04 | 5 | 57 | 2 | MP:0020452 | |
| MousePheno | abnormal left lung morphology | 1.96e-04 | 28 | 57 | 3 | MP:0009569 | |
| MousePheno | absent spleen | 2.18e-04 | 29 | 57 | 3 | MP:0000690 | |
| MousePheno | right-sided isomerism | 2.41e-04 | 30 | 57 | 3 | MP:0000508 | |
| MousePheno | right-sided stomach | 2.66e-04 | 31 | 57 | 3 | MP:0010808 | |
| MousePheno | superior-inferior ventricles | 3.39e-04 | 7 | 57 | 2 | MP:0011254 | |
| MousePheno | atrioventricular septal defect | 3.76e-04 | 84 | 57 | 4 | MP:0010412 | |
| MousePheno | abnormal stomach position or orientation | 4.17e-04 | 36 | 57 | 3 | MP:0010807 | |
| MousePheno | abnormal atrioventricular septum morphology | 4.30e-04 | 87 | 57 | 4 | MP:0010592 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | JAG2 SALL1 KMT2B MEGF8 KDM5A SLCO2A1 ZNF516 INSM1 CFC1 LRP1 LAMA3 SNX27 CFC1B NOTCH2 | 4.45e-04 | 1269 | 57 | 14 | MP:0011111 |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | JAG2 NRXN3 SALL1 KMT2B INSM1 CFC1 LRP1 LAMA2 LAMA4 LRP5 CFC1B LTBP4 NOTCH2 | 4.75e-04 | 1124 | 57 | 13 | MP:0011112 |
| MousePheno | abnormal direction of heart looping | 4.90e-04 | 38 | 57 | 3 | MP:0004252 | |
| Domain | EGF_1 | JAG2 NRXN3 MEGF6 MEGF8 PAMR1 CFC1 LRP1 LAMA2 LAMA3 LAMA4 LRP5 CFC1B LTBP2 CUBN LTBP4 SSPOP TNXB LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 2.60e-24 | 255 | 71 | 22 | PS00022 |
| Domain | EGF | JAG2 NRXN3 MEGF6 MEGF8 PAMR1 CFC1 LRP1 LAMA2 LAMA3 LAMA4 LRP5 CFC1B LTBP2 CUBN LTBP4 TNXB LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.58e-23 | 235 | 71 | 21 | SM00181 |
| Domain | EGF-like_dom | JAG2 NRXN3 MEGF6 MEGF8 PAMR1 CFC1 LRP1 LAMA2 LAMA3 LAMA4 LRP5 CFC1B LTBP2 CUBN LTBP4 TNXB LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.42e-23 | 249 | 71 | 21 | IPR000742 |
| Domain | EGF-like_CS | JAG2 NRXN3 MEGF6 MEGF8 PAMR1 CFC1 LRP1 LAMA2 LAMA3 LAMA4 LRP5 CFC1B LTBP2 CUBN LTBP4 TNXB LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.47e-22 | 261 | 71 | 21 | IPR013032 |
| Domain | EGF_2 | JAG2 NRXN3 MEGF6 MEGF8 PAMR1 CFC1 LRP1 LAMA2 LAMA3 LRP5 CFC1B LTBP2 CUBN LTBP4 SSPOP TNXB LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 2.03e-22 | 265 | 71 | 21 | PS01186 |
| Domain | EGF_3 | JAG2 NRXN3 MEGF6 MEGF8 PAMR1 CFC1 LRP1 LRP5 CFC1B LTBP2 CUBN LTBP4 SSPOP TNXB LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.83e-20 | 235 | 71 | 19 | PS50026 |
| Domain | Growth_fac_rcpt_ | JAG2 TNFRSF9 MEGF6 MEGF8 LRP1 LAMA3 LTBP2 CUBN LTBP4 TNXB LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 2.07e-17 | 156 | 71 | 15 | IPR009030 |
| Domain | EGF-like_Ca-bd_dom | JAG2 MEGF6 MEGF8 PAMR1 LRP1 LRP5 LTBP2 CUBN LTBP4 LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 2.66e-17 | 124 | 71 | 14 | IPR001881 |
| Domain | EGF_CA | JAG2 MEGF6 MEGF8 LRP1 LRP5 LTBP2 CUBN LTBP4 LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.21e-17 | 99 | 71 | 13 | PS01187 |
| Domain | ASX_HYDROXYL | JAG2 NRXN3 MEGF6 MEGF8 LRP1 LTBP2 CUBN LTBP4 LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.97e-17 | 100 | 71 | 13 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | JAG2 NRXN3 MEGF6 MEGF8 LRP1 LTBP2 CUBN LTBP4 LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.31e-16 | 106 | 71 | 13 | IPR000152 |
| Domain | EGF_CA | JAG2 MEGF6 MEGF8 LRP1 LTBP2 CUBN LTBP4 LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 4.21e-16 | 86 | 71 | 12 | PF07645 |
| Domain | EGF_CA | JAG2 MEGF6 MEGF8 PAMR1 LRP1 LTBP2 CUBN LTBP4 LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 8.65e-16 | 122 | 71 | 13 | SM00179 |
| Domain | EGF | JAG2 NRXN3 MEGF6 PAMR1 LRP1 LRP5 LTBP2 CUBN TNXB NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.33e-15 | 126 | 71 | 13 | PF00008 |
| Domain | EGF_Ca-bd_CS | JAG2 MEGF6 MEGF8 LRP1 LTBP2 CUBN LTBP4 LDLR NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 1.90e-15 | 97 | 71 | 12 | IPR018097 |
| Domain | Notch | 1.92e-10 | 4 | 71 | 4 | IPR008297 | |
| Domain | NODP | 1.92e-10 | 4 | 71 | 4 | PF07684 | |
| Domain | Notch_NODP_dom | 1.92e-10 | 4 | 71 | 4 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.92e-10 | 4 | 71 | 4 | IPR010660 | |
| Domain | NOD | 1.92e-10 | 4 | 71 | 4 | PF06816 | |
| Domain | NOD | 1.92e-10 | 4 | 71 | 4 | SM01338 | |
| Domain | NODP | 1.92e-10 | 4 | 71 | 4 | SM01339 | |
| Domain | hEGF | 8.58e-10 | 28 | 71 | 6 | PF12661 | |
| Domain | LNR | 9.56e-10 | 5 | 71 | 4 | PS50258 | |
| Domain | Notch_dom | 6.65e-09 | 7 | 71 | 4 | IPR000800 | |
| Domain | Notch | 6.65e-09 | 7 | 71 | 4 | PF00066 | |
| Domain | NL | 6.65e-09 | 7 | 71 | 4 | SM00004 | |
| Domain | - | TRIML1 KMT2D KMT2B USP51 TRIM58 KDM5A MYLIP NSD1 PHF7 BIRC7 TRIM48 NSD3 PDZRN4 | 1.23e-08 | 449 | 71 | 13 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | TRIML1 KMT2D KMT2B USP51 TRIM58 KDM5A MYLIP NSD1 PHF7 BIRC7 TRIM48 NSD3 PDZRN4 | 1.60e-08 | 459 | 71 | 13 | IPR013083 |
| Domain | DUF3454 | 5.26e-08 | 3 | 71 | 3 | PF11936 | |
| Domain | DUF3454_notch | 5.26e-08 | 3 | 71 | 3 | IPR024600 | |
| Domain | DUF3454 | 5.26e-08 | 3 | 71 | 3 | SM01334 | |
| Domain | EGF_extracell | 1.04e-07 | 60 | 71 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.04e-07 | 60 | 71 | 6 | PF07974 | |
| Domain | Laminin_EGF | 2.04e-07 | 35 | 71 | 5 | PF00053 | |
| Domain | EGF_Lam | 2.04e-07 | 35 | 71 | 5 | SM00180 | |
| Domain | RING | TRIML1 KMT2D TRIM58 MYLIP NSD1 PHF7 BIRC7 TRIM48 NSD3 PDZRN4 | 2.23e-07 | 305 | 71 | 10 | SM00184 |
| Domain | Laminin_EGF | 3.13e-07 | 38 | 71 | 5 | IPR002049 | |
| Domain | Post-SET_dom | 3.37e-07 | 16 | 71 | 4 | IPR003616 | |
| Domain | PostSET | 3.37e-07 | 16 | 71 | 4 | SM00508 | |
| Domain | POST_SET | 3.37e-07 | 16 | 71 | 4 | PS50868 | |
| Domain | Znf_RING | TRIML1 KMT2D TRIM58 MYLIP NSD1 PHF7 BIRC7 TRIM48 NSD3 PDZRN4 | 4.11e-07 | 326 | 71 | 10 | IPR001841 |
| Domain | Laminin_aI | 5.24e-07 | 5 | 71 | 3 | IPR009254 | |
| Domain | Laminin_I | 5.24e-07 | 5 | 71 | 3 | PF06008 | |
| Domain | Laminin_II | 5.24e-07 | 5 | 71 | 3 | PF06009 | |
| Domain | Laminin_domII | 5.24e-07 | 5 | 71 | 3 | IPR010307 | |
| Domain | PHD | 1.10e-06 | 89 | 71 | 6 | SM00249 | |
| Domain | Znf_PHD | 1.26e-06 | 91 | 71 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.62e-06 | 95 | 71 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.72e-06 | 96 | 71 | 6 | PS01359 | |
| Domain | EGF_LAM_2 | 4.88e-06 | 30 | 71 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 4.88e-06 | 30 | 71 | 4 | PS01248 | |
| Domain | PHD | 9.66e-06 | 75 | 71 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 1.25e-05 | 79 | 71 | 5 | IPR019787 | |
| Domain | LAM_G_DOMAIN | 1.28e-05 | 38 | 71 | 4 | PS50025 | |
| Domain | Tgfb1i1/Leupaxin | 1.42e-05 | 2 | 71 | 2 | IPR017305 | |
| Domain | ZF_RING_1 | 1.43e-05 | 291 | 71 | 8 | PS00518 | |
| Domain | LDLR_class-A_CS | 1.58e-05 | 40 | 71 | 4 | IPR023415 | |
| Domain | Laminin_G_2 | 1.58e-05 | 40 | 71 | 4 | PF02210 | |
| Domain | ZF_RING_2 | 1.70e-05 | 298 | 71 | 8 | PS50089 | |
| Domain | SET | 1.75e-05 | 41 | 71 | 4 | PF00856 | |
| Domain | Ldl_recept_b | 1.86e-05 | 14 | 71 | 3 | PF00058 | |
| Domain | LDLRB | 1.86e-05 | 14 | 71 | 3 | PS51120 | |
| Domain | Znf_FYVE_PHD | 2.02e-05 | 147 | 71 | 6 | IPR011011 | |
| Domain | LY | 2.32e-05 | 15 | 71 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.32e-05 | 15 | 71 | 3 | IPR000033 | |
| Domain | LamG | 2.32e-05 | 44 | 71 | 4 | SM00282 | |
| Domain | Ldl_recept_a | 2.54e-05 | 45 | 71 | 4 | PF00057 | |
| Domain | SET | 2.77e-05 | 46 | 71 | 4 | SM00317 | |
| Domain | - | 2.77e-05 | 46 | 71 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.29e-05 | 48 | 71 | 4 | PS01209 | |
| Domain | LDLRA_2 | 3.57e-05 | 49 | 71 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 3.57e-05 | 49 | 71 | 4 | IPR002172 | |
| Domain | LDLa | 3.57e-05 | 49 | 71 | 4 | SM00192 | |
| Domain | SET_dom | 3.87e-05 | 50 | 71 | 4 | IPR001214 | |
| Domain | SET | 3.87e-05 | 50 | 71 | 4 | PS50280 | |
| Domain | CFC | 4.26e-05 | 3 | 71 | 2 | PF09443 | |
| Domain | Cryptic/Cripto_CFC-dom | 4.26e-05 | 3 | 71 | 2 | IPR019011 | |
| Domain | VWC_out | 4.88e-05 | 19 | 71 | 3 | SM00215 | |
| Domain | Laminin_G | 6.97e-05 | 58 | 71 | 4 | IPR001791 | |
| Domain | EPHD | 7.70e-05 | 22 | 71 | 3 | PS51805 | |
| Domain | TNFR_c6 | 7.70e-05 | 22 | 71 | 3 | PF00020 | |
| Domain | TNFR | 1.29e-04 | 26 | 71 | 3 | SM00208 | |
| Domain | FYrich_C | 1.41e-04 | 5 | 71 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.41e-04 | 5 | 71 | 2 | IPR003888 | |
| Domain | AWS | 1.41e-04 | 5 | 71 | 2 | SM00570 | |
| Domain | FYRC | 1.41e-04 | 5 | 71 | 2 | SM00542 | |
| Domain | FYRN | 1.41e-04 | 5 | 71 | 2 | SM00541 | |
| Domain | AWS | 1.41e-04 | 5 | 71 | 2 | PS51215 | |
| Domain | AWS_dom | 1.41e-04 | 5 | 71 | 2 | IPR006560 | |
| Domain | FYRN | 1.41e-04 | 5 | 71 | 2 | PF05964 | |
| Domain | FYRC | 1.41e-04 | 5 | 71 | 2 | PF05965 | |
| Domain | FYRC | 1.41e-04 | 5 | 71 | 2 | PS51543 | |
| Domain | FYRN | 1.41e-04 | 5 | 71 | 2 | PS51542 | |
| Domain | TNFR_NGFR_1 | 1.79e-04 | 29 | 71 | 3 | PS00652 | |
| Domain | TNFR_NGFR_2 | 1.79e-04 | 29 | 71 | 3 | PS50050 | |
| Domain | ConA-like_dom | 1.84e-04 | 219 | 71 | 6 | IPR013320 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 2.65e-04 | 33 | 71 | 3 | IPR001368 | |
| Domain | TB | 2.96e-04 | 7 | 71 | 2 | PF00683 | |
| Domain | VWFC_1 | 3.44e-04 | 36 | 71 | 3 | PS01208 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 7.79e-10 | 13 | 53 | 5 | M47423 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 8.88e-10 | 5 | 53 | 4 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.66e-09 | 6 | 53 | 4 | M27068 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 4.69e-08 | 27 | 53 | 5 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 5.76e-08 | 11 | 53 | 4 | M47865 | |
| Pathway | PID_NOTCH_PATHWAY | 8.16e-08 | 59 | 53 | 6 | M17 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 8.62e-08 | 12 | 53 | 4 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 8.62e-08 | 12 | 53 | 4 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.24e-07 | 13 | 53 | 4 | M47534 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.93e-07 | 68 | 53 | 6 | M27303 | |
| Pathway | WP_CANCER_PATHWAYS | JAG2 ZBTB16 LAMA2 LAMA3 LAMA4 LRP5 BIRC7 VEGFD NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 2.86e-07 | 507 | 53 | 12 | M48302 |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.99e-07 | 5 | 53 | 3 | MM14733 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 5.24e-07 | 18 | 53 | 4 | M614 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 6.75e-07 | 45 | 53 | 5 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 7.55e-07 | 46 | 53 | 5 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 8.43e-07 | 47 | 53 | 5 | M7946 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.74e-06 | 7 | 53 | 3 | MM14734 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.79e-06 | 24 | 53 | 4 | M11190 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.14e-06 | 61 | 53 | 5 | M39540 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.41e-06 | 28 | 53 | 4 | M6177 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 5.04e-06 | 118 | 53 | 6 | M39852 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 7.60e-06 | 34 | 53 | 4 | M39390 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.33e-05 | 39 | 53 | 4 | MM14604 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.36e-05 | 82 | 53 | 5 | MM15922 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.52e-05 | 143 | 53 | 6 | M27275 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 2.32e-05 | 154 | 53 | 6 | M39739 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 2.58e-05 | 46 | 53 | 4 | MM14933 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.71e-05 | 16 | 53 | 3 | M47424 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.98e-05 | 161 | 53 | 6 | M39770 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.90e-05 | 250 | 53 | 7 | M27554 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.47e-05 | 20 | 53 | 3 | M27881 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 8.43e-05 | 23 | 53 | 3 | MM14954 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.36e-04 | 70 | 53 | 4 | M27231 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.87e-04 | 76 | 53 | 4 | M27219 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.90e-04 | 30 | 53 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.90e-04 | 30 | 53 | 3 | M27216 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.09e-04 | 31 | 53 | 3 | MM1343 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 2.53e-04 | 33 | 53 | 3 | M6220 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.75e-04 | 84 | 53 | 4 | M7098 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 2.88e-04 | 7 | 53 | 2 | M27199 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 3.56e-04 | 37 | 53 | 3 | M27847 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 3.56e-04 | 37 | 53 | 3 | M39506 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 4.58e-04 | 96 | 53 | 4 | M39834 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 4.76e-04 | 97 | 53 | 4 | MM15926 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.84e-04 | 41 | 53 | 3 | M27778 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.93e-04 | 175 | 53 | 5 | MM14941 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 5.55e-04 | 101 | 53 | 4 | M39448 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 6.12e-04 | 10 | 53 | 2 | MM14849 | |
| Pathway | WP_FOCAL_ADHESION | 6.67e-04 | 187 | 53 | 5 | MM15913 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 6.80e-04 | 46 | 53 | 3 | M239 | |
| Pathway | WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER | 6.80e-04 | 46 | 53 | 3 | M46466 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 7.46e-04 | 11 | 53 | 2 | M158 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 8.18e-04 | 49 | 53 | 3 | M618 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.75e-04 | 300 | 53 | 6 | M610 | |
| Pathway | WP_FOCAL_ADHESION | 8.83e-04 | 199 | 53 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 8.83e-04 | 199 | 53 | 5 | M7253 | |
| Pathway | BIOCARTA_HES_PATHWAY | 8.94e-04 | 12 | 53 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 8.94e-04 | 12 | 53 | 2 | M22042 | |
| Pathway | WP_MIR127_IN_MESENDODERM_DIFFERENTIATION | 8.94e-04 | 12 | 53 | 2 | MM15910 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.03e-03 | 119 | 53 | 4 | M607 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 1.05e-03 | 13 | 53 | 2 | M42551 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.41e-03 | 59 | 53 | 3 | M27218 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.41e-03 | 15 | 53 | 2 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.41e-03 | 15 | 53 | 2 | M27202 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5 | 1.41e-03 | 15 | 53 | 2 | M42552 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.82e-03 | 17 | 53 | 2 | M39389 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 1.86e-03 | 65 | 53 | 3 | M39374 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.94e-03 | 66 | 53 | 3 | M18 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.04e-03 | 18 | 53 | 2 | MM14775 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1 | 2.04e-03 | 18 | 53 | 2 | M42559 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.25e-03 | 246 | 53 | 5 | M10189 | |
| Pathway | WP_STATIN_PATHWAY | 2.28e-03 | 19 | 53 | 2 | MM15868 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.28e-03 | 19 | 53 | 2 | MM15594 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.28e-03 | 19 | 53 | 2 | MM15512 | |
| Pathway | WP_CHOLESTEROL_METABOLISM | 2.49e-03 | 72 | 53 | 3 | M46457 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.77e-03 | 258 | 53 | 5 | MM14572 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 2.80e-03 | 75 | 53 | 3 | M27032 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 2.94e-03 | 381 | 53 | 6 | M48063 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.05e-03 | 22 | 53 | 2 | M27210 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4 | 3.05e-03 | 22 | 53 | 2 | M42574 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.24e-03 | 79 | 53 | 3 | M27643 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.47e-03 | 272 | 53 | 5 | M29619 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 3.60e-03 | 82 | 53 | 3 | M594 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.86e-03 | 84 | 53 | 3 | M3228 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.94e-03 | 25 | 53 | 2 | M27880 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.94e-03 | 25 | 53 | 2 | M27879 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 4.25e-03 | 26 | 53 | 2 | M39407 | |
| Pathway | REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS | 4.25e-03 | 26 | 53 | 2 | MM15270 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 4.26e-03 | 87 | 53 | 3 | M39465 | |
| Pathway | REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS | 5.28e-03 | 29 | 53 | 2 | M27555 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 5.33e-03 | 301 | 53 | 5 | MM15983 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.41e-03 | 302 | 53 | 5 | M39719 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.64e-03 | 30 | 53 | 2 | MM15517 | |
| Pathway | REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY | 5.77e-03 | 97 | 53 | 3 | MM15268 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 6.01e-03 | 31 | 53 | 2 | M592 | |
| Pathway | WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION | 6.01e-03 | 31 | 53 | 2 | M39514 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.40e-03 | 32 | 53 | 2 | MM14854 | |
| Pathway | REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY | 6.45e-03 | 101 | 53 | 3 | M27552 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 6.63e-03 | 102 | 53 | 3 | MM15498 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 6.80e-03 | 33 | 53 | 2 | M39503 | |
| Pubmed | 7.95e-13 | 7 | 74 | 5 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 7.95e-13 | 7 | 74 | 5 | 12846471 | |
| Pubmed | 2.12e-12 | 8 | 74 | 5 | 9858718 | ||
| Pubmed | 4.76e-12 | 9 | 74 | 5 | 11118901 | ||
| Pubmed | 4.76e-12 | 9 | 74 | 5 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 9.50e-12 | 10 | 74 | 5 | 23665443 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 1.74e-11 | 11 | 74 | 5 | 16607638 | |
| Pubmed | 1.74e-11 | 11 | 74 | 5 | 10878608 | ||
| Pubmed | 1.74e-11 | 11 | 74 | 5 | 12866128 | ||
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 24145721 | ||
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 1.89e-11 | 4 | 74 | 4 | 19404845 | |
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 28669409 | ||
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 11401408 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 1.89e-11 | 4 | 74 | 4 | 8898100 | |
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 1.89e-11 | 4 | 74 | 4 | 17920003 | |
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 1.89e-11 | 4 | 74 | 4 | 28061457 | |
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 11466531 | ||
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 24151014 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 1.89e-11 | 4 | 74 | 4 | 10194420 | |
| Pubmed | 1.89e-11 | 4 | 74 | 4 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 1.89e-11 | 4 | 74 | 4 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 1.89e-11 | 4 | 74 | 4 | 15917835 | |
| Pubmed | 2.97e-11 | 12 | 74 | 5 | 15465494 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 3.45e-11 | 29 | 74 | 6 | 21402740 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 4.83e-11 | 13 | 74 | 5 | 11578869 | |
| Pubmed | 7.50e-11 | 14 | 74 | 5 | 14757642 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 11101851 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 21124806 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 9.42e-11 | 5 | 74 | 4 | 15064243 | |
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 23675950 | ||
| Pubmed | 9.42e-11 | 5 | 74 | 4 | 15882997 | ||
| Pubmed | 1.12e-10 | 15 | 74 | 5 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.63e-10 | 16 | 74 | 5 | 12617809 | |
| Pubmed | 1.63e-10 | 16 | 74 | 5 | 17273555 | ||
| Pubmed | 1.63e-10 | 16 | 74 | 5 | 10842072 | ||
| Pubmed | 2.31e-10 | 17 | 74 | 5 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 2.31e-10 | 17 | 74 | 5 | 15821257 | |
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 9111338 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 2.82e-10 | 6 | 74 | 4 | 12244553 | |
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 18299578 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 2.82e-10 | 6 | 74 | 4 | 15019995 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 2.82e-10 | 6 | 74 | 4 | 22615412 | |
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 20870902 | ||
| Pubmed | 2.82e-10 | 6 | 74 | 4 | 19503073 | ||
| Pubmed | Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. | 2.82e-10 | 6 | 74 | 4 | 21991352 | |
| Pubmed | 3.19e-10 | 18 | 74 | 5 | 18093989 | ||
| Pubmed | 3.19e-10 | 18 | 74 | 5 | 15689374 | ||
| Pubmed | 3.20e-10 | 41 | 74 | 6 | 22675208 | ||
| Pubmed | 4.32e-10 | 19 | 74 | 5 | 16518823 | ||
| Pubmed | 6.58e-10 | 7 | 74 | 4 | 10383933 | ||
| Pubmed | Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. | 6.58e-10 | 7 | 74 | 4 | 11518718 | |
| Pubmed | 6.58e-10 | 7 | 74 | 4 | 16169548 | ||
| Pubmed | 7.53e-10 | 21 | 74 | 5 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 7.53e-10 | 21 | 74 | 5 | 14702043 | |
| Pubmed | 9.73e-10 | 22 | 74 | 5 | 34998785 | ||
| Pubmed | 1.24e-09 | 23 | 74 | 5 | 14701881 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.31e-09 | 8 | 74 | 4 | 22652674 | |
| Pubmed | 1.31e-09 | 8 | 74 | 4 | 11044610 | ||
| Pubmed | 1.31e-09 | 8 | 74 | 4 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.31e-09 | 8 | 74 | 4 | 12242716 | |
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 1.57e-09 | 24 | 74 | 5 | 21420948 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.16e-09 | 101 | 74 | 7 | 23382219 | |
| Pubmed | 2.36e-09 | 9 | 74 | 4 | 12370315 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 2.41e-09 | 26 | 74 | 5 | 19369401 | |
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 2.96e-09 | 27 | 74 | 5 | 21791528 | |
| Pubmed | 3.93e-09 | 10 | 74 | 4 | 33915108 | ||
| Pubmed | 3.97e-09 | 175 | 74 | 8 | 28071719 | ||
| Pubmed | 4.34e-09 | 29 | 74 | 5 | 25535917 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 5.20e-09 | 30 | 74 | 5 | 24552588 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 6.16e-09 | 11 | 74 | 4 | 9187150 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 6.16e-09 | 11 | 74 | 4 | 15499562 | |
| Pubmed | 6.18e-09 | 31 | 74 | 5 | 37573008 | ||
| Pubmed | 9.22e-09 | 12 | 74 | 4 | 10952889 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 9.25e-09 | 3 | 74 | 3 | 25846406 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 8645602 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 27566587 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 27697639 | ||
| Pubmed | Differential expression of Notch genes in human osteoblastic cells. | 9.25e-09 | 3 | 74 | 3 | 11836628 | |
| Pubmed | Notch signaling: cell fate control and signal integration in development. | 9.25e-09 | 3 | 74 | 3 | 10221902 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 7615640 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 7918097 | ||
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 9.25e-09 | 3 | 74 | 3 | 21471519 | |
| Pubmed | Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | 9.25e-09 | 3 | 74 | 3 | 18458347 | |
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 9.25e-09 | 3 | 74 | 3 | 29767458 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 7698746 | ||
| Pubmed | The Notch-mediated circuitry in the evolution and generation of new cell lineages: the tooth model. | 9.25e-09 | 3 | 74 | 3 | 37330998 | |
| Pubmed | 1.01e-08 | 34 | 74 | 5 | 21311046 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 1.17e-08 | 35 | 74 | 5 | 21252157 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 1.33e-08 | 13 | 74 | 4 | 31202705 | |
| Pubmed | A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. | 1.33e-08 | 13 | 74 | 4 | 32929274 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 1.33e-08 | 13 | 74 | 4 | 20558824 | |
| Pubmed | 1.57e-08 | 37 | 74 | 5 | 24673559 | ||
| Pubmed | Cell-fate transition and determination analysis of mouse male germ cells throughout development. | 1.86e-08 | 14 | 74 | 4 | 34824237 | |
| Pubmed | 1.86e-08 | 14 | 74 | 4 | 28192800 | ||
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 33730615 | ||
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 17194759 | ||
| Pubmed | Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. | 2.53e-08 | 15 | 74 | 4 | 14672936 | |
| Pubmed | 2.53e-08 | 15 | 74 | 4 | 9291577 | ||
| Interaction | NTN5 interactions | 1.81e-10 | 24 | 70 | 6 | int:NTN5 | |
| Interaction | IGFL3 interactions | 7.38e-09 | 75 | 70 | 7 | int:IGFL3 | |
| Interaction | MFAP5 interactions | 2.53e-08 | 52 | 70 | 6 | int:MFAP5 | |
| Interaction | ZNF74 interactions | 1.12e-07 | 34 | 70 | 5 | int:ZNF74 | |
| Interaction | IGSF5 interactions | 1.30e-07 | 14 | 70 | 4 | int:IGSF5 | |
| Interaction | MBD1 interactions | 2.76e-07 | 77 | 70 | 6 | int:MBD1 | |
| Interaction | MAML2 interactions | 3.07e-07 | 17 | 70 | 4 | int:MAML2 | |
| Interaction | HOXA1 interactions | TGFB1I1 JAG2 ZBTB16 MEGF6 MEGF8 LPXN TSPAN4 LTBP4 NOTCH1 NOTCH3 | 4.04e-07 | 356 | 70 | 10 | int:HOXA1 |
| Interaction | MAML3 interactions | 6.20e-07 | 20 | 70 | 4 | int:MAML3 | |
| Interaction | WNT3A interactions | 7.40e-07 | 49 | 70 | 5 | int:WNT3A | |
| Interaction | ZFP41 interactions | 1.59e-06 | 57 | 70 | 5 | int:ZFP41 | |
| Interaction | EDN3 interactions | 2.04e-06 | 108 | 70 | 6 | int:EDN3 | |
| Interaction | CACNA1A interactions | 4.36e-06 | 123 | 70 | 6 | int:CACNA1A | |
| Interaction | CFC1 interactions | 5.01e-06 | 126 | 70 | 6 | int:CFC1 | |
| Interaction | EGFL7 interactions | 7.12e-06 | 77 | 70 | 5 | int:EGFL7 | |
| Interaction | ST14 interactions | 7.55e-06 | 207 | 70 | 7 | int:ST14 | |
| Interaction | ZNF707 interactions | 8.07e-06 | 79 | 70 | 5 | int:ZNF707 | |
| Interaction | WNT10A interactions | 8.08e-06 | 37 | 70 | 4 | int:WNT10A | |
| Interaction | SLURP1 interactions | 1.08e-05 | 144 | 70 | 6 | int:SLURP1 | |
| Interaction | FBXO2 interactions | 1.21e-05 | 411 | 70 | 9 | int:FBXO2 | |
| Interaction | JAG1 interactions | 1.23e-05 | 41 | 70 | 4 | int:JAG1 | |
| Interaction | FOXD4L6 interactions | 2.51e-05 | 49 | 70 | 4 | int:FOXD4L6 | |
| Interaction | RBPJ interactions | 2.84e-05 | 254 | 70 | 7 | int:RBPJ | |
| Interaction | CCN6 interactions | 3.74e-05 | 19 | 70 | 3 | int:CCN6 | |
| Interaction | ATXN7 interactions | 3.86e-05 | 109 | 70 | 5 | int:ATXN7 | |
| Interaction | NOTCH3 interactions | 4.59e-05 | 113 | 70 | 5 | int:NOTCH3 | |
| Interaction | ATN1 interactions | 4.72e-05 | 187 | 70 | 6 | int:ATN1 | |
| Interaction | LYPD1 interactions | 4.91e-05 | 58 | 70 | 4 | int:LYPD1 | |
| Interaction | NOTCH4 interactions | 5.10e-05 | 21 | 70 | 3 | int:NOTCH4 | |
| Interaction | PRG2 interactions | 5.89e-05 | 285 | 70 | 7 | int:PRG2 | |
| Interaction | CASR interactions | 5.89e-05 | 22 | 70 | 3 | int:CASR | |
| Interaction | PLAT interactions | 6.81e-05 | 63 | 70 | 4 | int:PLAT | |
| Interaction | LTBP4 interactions | 8.67e-05 | 67 | 70 | 4 | int:LTBP4 | |
| Interaction | MARCHF1 interactions | 1.03e-04 | 70 | 70 | 4 | int:MARCHF1 | |
| Interaction | NOTCH2 interactions | 1.07e-04 | 423 | 70 | 8 | int:NOTCH2 | |
| Interaction | GFI1B interactions | 1.11e-04 | 136 | 70 | 5 | int:GFI1B | |
| Interaction | MAML1 interactions | 1.21e-04 | 73 | 70 | 4 | int:MAML1 | |
| Interaction | ASNSD1 interactions | 1.37e-04 | 29 | 70 | 3 | int:ASNSD1 | |
| Interaction | ZNF408 interactions | 1.50e-04 | 145 | 70 | 5 | int:ZNF408 | |
| Interaction | DLL4 interactions | 1.77e-04 | 6 | 70 | 2 | int:DLL4 | |
| Interaction | PSEN2 interactions | 2.29e-04 | 86 | 70 | 4 | int:PSEN2 | |
| Interaction | SIRPD interactions | 2.29e-04 | 86 | 70 | 4 | int:SIRPD | |
| Interaction | ZNF594 interactions | 2.47e-04 | 7 | 70 | 2 | int:ZNF594 | |
| Interaction | DLK2 interactions | 2.64e-04 | 36 | 70 | 3 | int:DLK2 | |
| Interaction | TIMP3 interactions | 2.72e-04 | 90 | 70 | 4 | int:TIMP3 | |
| Interaction | GREM2 interactions | 2.87e-04 | 37 | 70 | 3 | int:GREM2 | |
| Interaction | LTBP1 interactions | 2.96e-04 | 92 | 70 | 4 | int:LTBP1 | |
| Interaction | DLL1 interactions | 3.10e-04 | 38 | 70 | 3 | int:DLL1 | |
| Interaction | IGFBP4 interactions | 3.89e-04 | 41 | 70 | 3 | int:IGFBP4 | |
| Interaction | PROS1 interactions | 4.18e-04 | 42 | 70 | 3 | int:PROS1 | |
| Interaction | ZNF480 interactions | 4.21e-04 | 9 | 70 | 2 | int:ZNF480 | |
| Interaction | ZKSCAN2 interactions | 4.21e-04 | 9 | 70 | 2 | int:ZKSCAN2 | |
| Interaction | TOP3B interactions | JAG2 ZC3H11A KMT2D KMT2B MEGF6 MEGF8 ZNF516 NSD1 LRP5 LTBP4 LDLR NOTCH1 NOTCH2 NSD3 | 4.57e-04 | 1470 | 70 | 14 | int:TOP3B |
| Interaction | ZNF766 interactions | 5.26e-04 | 10 | 70 | 2 | int:ZNF766 | |
| Interaction | KLK5 interactions | 5.64e-04 | 109 | 70 | 4 | int:KLK5 | |
| Interaction | JAG2 interactions | 5.84e-04 | 110 | 70 | 4 | int:JAG2 | |
| Interaction | ANKRD44 interactions | 6.21e-04 | 48 | 70 | 3 | int:ANKRD44 | |
| Interaction | C9orf163 interactions | 7.42e-04 | 51 | 70 | 3 | int:C9orf163 | |
| Interaction | ZNF555 interactions | 7.67e-04 | 12 | 70 | 2 | int:ZNF555 | |
| Interaction | ZNF611 interactions | 7.67e-04 | 12 | 70 | 2 | int:ZNF611 | |
| Interaction | TRAF4 interactions | 7.84e-04 | 208 | 70 | 5 | int:TRAF4 | |
| GeneFamily | PHD finger proteins | 4.68e-07 | 90 | 59 | 6 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.41e-06 | 34 | 59 | 4 | 487 | |
| GeneFamily | Laminin subunits | 7.11e-06 | 12 | 59 | 3 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 9.22e-06 | 13 | 59 | 3 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 6.26e-05 | 4 | 59 | 2 | 628 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.14e-04 | 29 | 59 | 3 | 782 | |
| GeneFamily | Ring finger proteins | 2.01e-03 | 275 | 59 | 5 | 58 | |
| GeneFamily | PWWP domain containing | 2.32e-03 | 22 | 59 | 2 | 1147 | |
| GeneFamily | CD molecules|Complement system|LY6/PLAUR domain containing | 5.49e-03 | 34 | 59 | 2 | 1226 | |
| GeneFamily | Zinc fingers CCCH-type | 5.81e-03 | 35 | 59 | 2 | 73 | |
| GeneFamily | Ankyrin repeat domain containing | 8.01e-03 | 242 | 59 | 4 | 403 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.22e-10 | 16 | 73 | 5 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.22e-10 | 16 | 73 | 5 | M2207 | |
| Coexpression | NABA_MATRISOME | MEGF6 MEGF8 PAMR1 CFC1 LAMA2 LAMA3 LAMA4 CFC1B LTBP2 VEGFD LTBP4 SSPOP MUC5AC TNXB | 6.31e-07 | 1008 | 73 | 14 | MM17056 |
| Coexpression | NABA_MATRISOME | MEGF6 MEGF8 PAMR1 CFC1 LAMA2 LAMA3 LAMA4 CFC1B LTBP2 VEGFD LTBP4 SSPOP MUC5AC TNXB | 7.78e-07 | 1026 | 73 | 14 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.06e-06 | 191 | 73 | 7 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.26e-06 | 196 | 73 | 7 | M3008 | |
| Coexpression | LEE_BMP2_TARGETS_UP | TGFB1I1 ZBTB16 PAMR1 SH3BGR MYLIP LRP1 LAMA2 REPS2 LTBP4 TNXB NOTCH3 | 1.00e-05 | 780 | 73 | 11 | M2324 |
| Coexpression | NABA_CORE_MATRISOME | 1.04e-05 | 270 | 73 | 7 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.17e-05 | 275 | 73 | 7 | M5884 | |
| Coexpression | LEE_BMP2_TARGETS_UP | TGFB1I1 ZBTB16 PAMR1 SH3BGR MYLIP LRP1 LAMA2 REPS2 LTBP4 TNXB NOTCH3 | 1.34e-05 | 805 | 73 | 11 | MM1067 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | JAG2 CLCN4 MEGF6 MEGF8 LRP1 LAMA2 LTBP4 TNXB F11 NOTCH3 TMEM63A | 4.10e-05 | 909 | 73 | 11 | M41018 |
| Coexpression | BMI1_DN.V1_UP | 5.73e-05 | 147 | 73 | 5 | M2782 | |
| Coexpression | SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN | 6.33e-05 | 245 | 73 | 6 | M41070 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 7.10e-05 | 365 | 73 | 7 | M39018 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 8.97e-05 | 261 | 73 | 6 | M1834 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 9.70e-05 | 32 | 73 | 3 | M5903 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 1.45e-04 | 179 | 73 | 5 | M41745 | |
| Coexpression | NOTCH_DN.V1_DN | 1.61e-04 | 183 | 73 | 5 | M2788 | |
| Coexpression | TOMLINS_PROSTATE_CANCER_DN | 1.90e-04 | 40 | 73 | 3 | M11504 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.90e-04 | 40 | 73 | 3 | M5887 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 2.12e-04 | 8 | 73 | 2 | M9884 | |
| Coexpression | GSE45837_WT_VS_GFI1_KO_PDC_UP | 2.16e-04 | 195 | 73 | 5 | M9892 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 2.20e-04 | 42 | 73 | 3 | M5895 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP | 2.37e-04 | 199 | 73 | 5 | M8105 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP | 2.37e-04 | 199 | 73 | 5 | M5009 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN | 2.43e-04 | 200 | 73 | 5 | M6366 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP | 2.43e-04 | 200 | 73 | 5 | M8212 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN | 2.43e-04 | 200 | 73 | 5 | M9933 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_DN | 2.43e-04 | 200 | 73 | 5 | M3079 | |
| Coexpression | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP | 2.72e-04 | 9 | 73 | 2 | M18679 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 2.72e-04 | 9 | 73 | 2 | M9630 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 3.24e-04 | 213 | 73 | 5 | M12176 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | PAMR1 SLCO2A1 TSPAN4 LRP1 LAMA4 LTBP2 VEGFD LTBP4 TNXB NOTCH3 | 2.32e-06 | 455 | 70 | 10 | GSM777055_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.74e-05 | 453 | 70 | 9 | GSM777067_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 1.83e-05 | 456 | 70 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.17e-05 | 466 | 70 | 9 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.41e-05 | 51 | 70 | 4 | gudmap_developingGonad_P2_testes_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.09e-04 | 229 | 70 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 1.56e-04 | 82 | 70 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 1.60e-04 | 155 | 70 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.12e-04 | 369 | 70 | 7 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#3_top-relative-expression-ranked_100 | 2.23e-04 | 7 | 70 | 2 | gudmap_kidney_adult_RenalCapsule_k3_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | SLCO2A1 LRP1 LAMA2 L3HYPDH LTBP2 REPS2 VEGFD LTBP4 TNXB TMEM63A | 2.23e-04 | 778 | 70 | 10 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#5_top-relative-expression-ranked_200 | 2.27e-04 | 36 | 70 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.76e-04 | 799 | 70 | 10 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-11 | 200 | 74 | 9 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-11 | 200 | 74 | 9 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-10 | 188 | 74 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-09 | 190 | 74 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-09 | 196 | 74 | 8 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-09 | 199 | 74 | 8 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-09 | 200 | 74 | 8 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-09 | 200 | 74 | 8 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-09 | 200 | 74 | 8 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-09 | 200 | 74 | 8 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-09 | 200 | 74 | 8 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-09 | 200 | 74 | 8 | 87177c973e722ac7d9ee503b9cfacd84fc67865d | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-09 | 200 | 74 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.55e-09 | 200 | 74 | 8 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-09 | 200 | 74 | 8 | cbf6a6c3db88bac37bd084a3a914b12b3af524eb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-08 | 171 | 74 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-08 | 174 | 74 | 7 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-08 | 174 | 74 | 7 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-08 | 175 | 74 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-08 | 187 | 74 | 7 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-08 | 187 | 74 | 7 | 976b74d081b7fba8620768613cc26f9262cd7b16 | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.93e-08 | 189 | 74 | 7 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.93e-08 | 189 | 74 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.15e-08 | 191 | 74 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-08 | 191 | 74 | 7 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.26e-08 | 192 | 74 | 7 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-08 | 193 | 74 | 7 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-08 | 193 | 74 | 7 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-08 | 193 | 74 | 7 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-08 | 194 | 74 | 7 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 3.50e-08 | 194 | 74 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.50e-08 | 194 | 74 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-08 | 194 | 74 | 7 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-08 | 194 | 74 | 7 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-08 | 194 | 74 | 7 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-08 | 194 | 74 | 7 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-08 | 194 | 74 | 7 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.50e-08 | 194 | 74 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-08 | 194 | 74 | 7 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-08 | 195 | 74 | 7 | 2eed0332e338d6f0dbcb399d9d36c4611d491b0a | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.63e-08 | 195 | 74 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-08 | 195 | 74 | 7 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-08 | 195 | 74 | 7 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-08 | 195 | 74 | 7 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-08 | 195 | 74 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-08 | 196 | 74 | 7 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 4.03e-08 | 198 | 74 | 7 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.17e-08 | 199 | 74 | 7 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-08 | 199 | 74 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-08 | 199 | 74 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-08 | 200 | 74 | 7 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.32e-08 | 200 | 74 | 7 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-08 | 200 | 74 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.32e-08 | 200 | 74 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.32e-08 | 200 | 74 | 7 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-08 | 200 | 74 | 7 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.32e-08 | 200 | 74 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 4.32e-08 | 200 | 74 | 7 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.32e-08 | 200 | 74 | 7 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.72e-07 | 168 | 74 | 6 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-07 | 168 | 74 | 6 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-07 | 184 | 74 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-07 | 184 | 74 | 6 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-07 | 185 | 74 | 6 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-07 | 185 | 74 | 6 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.75e-07 | 186 | 74 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.97e-07 | 187 | 74 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.97e-07 | 187 | 74 | 6 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-07 | 188 | 74 | 6 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.19e-07 | 188 | 74 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.19e-07 | 188 | 74 | 6 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 7.42e-07 | 189 | 74 | 6 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-07 | 189 | 74 | 6 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-07 | 189 | 74 | 6 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.42e-07 | 189 | 74 | 6 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.42e-07 | 189 | 74 | 6 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-07 | 190 | 74 | 6 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.65e-07 | 190 | 74 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.89e-07 | 191 | 74 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-07 | 191 | 74 | 6 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.89e-07 | 191 | 74 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-07 | 191 | 74 | 6 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-07 | 191 | 74 | 6 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-07 | 191 | 74 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.89e-07 | 191 | 74 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-07 | 191 | 74 | 6 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-07 | 192 | 74 | 6 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-07 | 192 | 74 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-07 | 192 | 74 | 6 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-07 | 192 | 74 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-07 | 192 | 74 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-07 | 192 | 74 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.13e-07 | 192 | 74 | 6 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-07 | 192 | 74 | 6 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-07 | 192 | 74 | 6 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-07 | 193 | 74 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-07 | 193 | 74 | 6 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-07 | 193 | 74 | 6 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 8.38e-07 | 193 | 74 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-07 | 193 | 74 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A | 2.99e-06 | 197 | 72 | 7 | 7292_UP | |
| Drug | AC1L1G72 | 4.91e-06 | 11 | 72 | 3 | CID000003553 | |
| Drug | DB08434 | 2.95e-05 | 3 | 72 | 2 | CID005289220 | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; PC3; HT_HG-U133A | 3.37e-05 | 193 | 72 | 6 | 4569_UP | |
| Drug | STOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A | 3.47e-05 | 194 | 72 | 6 | 6380_DN | |
| Drug | Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.57e-05 | 195 | 72 | 6 | 5440_UP | |
| Drug | Suxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.57e-05 | 195 | 72 | 6 | 6065_UP | |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.57e-05 | 195 | 72 | 6 | 3542_UP | |
| Drug | PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.67e-05 | 196 | 72 | 6 | 5974_DN | |
| Drug | Doxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; PC3; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 6337_UP | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 6714_UP | |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 3096_DN | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 6703_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 2702_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 2288_UP | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 72 | 6 | 5617_UP | |
| Drug | Azaperone [1649-18-9]; Up 200; 12.2uM; HL60; HT_HG-U133A | 4.00e-05 | 199 | 72 | 6 | 6151_UP | |
| Drug | TTNPB; Down 200; 0.1uM; MCF7; HG-U133A | 4.00e-05 | 199 | 72 | 6 | 223_DN | |
| Drug | gamma-secretase inhibitor I | 5.89e-05 | 4 | 72 | 2 | CID011754711 | |
| Drug | dysprosium | 8.95e-05 | 74 | 72 | 4 | CID000023912 | |
| Drug | AC1L1B58 | 1.04e-04 | 29 | 72 | 3 | CID000001288 | |
| Drug | YIGSR | 1.15e-04 | 79 | 72 | 4 | CID000123977 | |
| Drug | fenoxycarb | 1.21e-04 | 80 | 72 | 4 | CID000051605 | |
| Drug | lead stearate | 1.47e-04 | 84 | 72 | 4 | CID000061258 | |
| Drug | vgBE | 1.47e-04 | 6 | 72 | 2 | CID000193461 | |
| Drug | 1,2-dimethylhydrazine | 1.60e-04 | 86 | 72 | 4 | CID000001322 | |
| Drug | 2-hydroxypropyl-beta-cyclodextrin | 2.05e-04 | 7 | 72 | 2 | ctd:C053839 | |
| Drug | Coagulation Factor IX | 2.05e-04 | 7 | 72 | 2 | DB00100 | |
| Drug | MW167 | 2.05e-04 | 7 | 72 | 2 | CID010312597 | |
| Drug | 1g2m | 2.05e-04 | 7 | 72 | 2 | CID000445756 | |
| Drug | flurbiprofen | 2.10e-04 | 171 | 72 | 5 | CID000003394 | |
| Drug | Calcort | 2.36e-04 | 38 | 72 | 3 | CID000026709 | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.46e-04 | 177 | 72 | 5 | 4495_UP | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.66e-04 | 180 | 72 | 5 | 3637_UP | |
| Drug | tesmilifene | 2.73e-04 | 8 | 72 | 2 | ctd:C043062 | |
| Drug | silver(I) fluoride | 2.73e-04 | 8 | 72 | 2 | CID000165912 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 3.10e-04 | 186 | 72 | 5 | 4463_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 3.10e-04 | 186 | 72 | 5 | 4271_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 3.42e-04 | 190 | 72 | 5 | 4274_UP | |
| Drug | 5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 3.50e-04 | 191 | 72 | 5 | 844_UP | |
| Drug | AC1NOYSL | 3.50e-04 | 9 | 72 | 2 | CID005121219 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; PC3; HT_HG-U133A | 3.58e-04 | 192 | 72 | 5 | 6664_DN | |
| Drug | phenanthridinone; Up 200; 51.2uM; MCF7; HT_HG-U133A_EA | 3.67e-04 | 193 | 72 | 5 | 1115_UP | |
| Drug | eicosane | 3.71e-04 | 107 | 72 | 4 | CID000008222 | |
| Drug | ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A | 3.76e-04 | 194 | 72 | 5 | 6165_DN | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 2804_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 6635_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 7539_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 2223_DN | |
| Drug | 17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.85e-04 | 195 | 72 | 5 | 6172_UP | |
| Drug | CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 7512_UP | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 4361_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 3817_UP | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 5606_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 5577_UP | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 3790_DN | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; HL60; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 2531_DN | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 4307_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 4570_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 4594_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; HL60; HG-U133A | 3.94e-04 | 196 | 72 | 5 | 1440_UP | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 5962_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 5088_UP | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 3729_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Down 200; 17uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 3720_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 3.94e-04 | 196 | 72 | 5 | 6673_DN | |
| Drug | nifedipine; Up 200; 10uM; MCF7; HG-U133A | 4.03e-04 | 197 | 72 | 5 | 335_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 7533_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 3784_DN | |
| Drug | rotenone; Down 200; 1uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 5948_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 6679_UP | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4583_DN | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 4266_UP | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 6341_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 5664_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 2812_UP | |
| Drug | Lidoflazine [3416-26-0]; Up 200; 8.2uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 5804_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; PC3; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 3727_UP | |
| Drug | Hecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.03e-04 | 197 | 72 | 5 | 3457_UP | |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; HL60; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 1268_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 4698_UP | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; HL60; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 6137_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 5972_DN | |
| Drug | U-62066 [87151-85-7]; Up 200; 1uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 4553_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 6197_DN | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 6019_UP | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 2281_UP | |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 6751_UP | |
| Drug | Nicergoline; Up 200; 8.2uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 2220_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 4595_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HG-U133A | 4.13e-04 | 198 | 72 | 5 | 23_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 6603_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; HL60; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 3033_UP | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 3793_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 4280_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 7296_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; PC3; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 3739_UP | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 6460_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; HL60; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 2182_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 4.13e-04 | 198 | 72 | 5 | 2256_DN | |
| Disease | Malignant neoplasm of breast | JAG2 TRIML1 ZC3H11A KMT2D CD40 TSPAN4 LAMA2 PHF7 CUBN REPS2 CTU1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 5.78e-08 | 1074 | 74 | 15 | C0006142 |
| Disease | Carcinoma, Pancreatic Ductal | 3.73e-07 | 24 | 74 | 4 | C0887833 | |
| Disease | Malignant neoplasm of skin | 3.90e-07 | 59 | 74 | 5 | C0007114 | |
| Disease | Skin Neoplasms | 3.90e-07 | 59 | 74 | 5 | C0037286 | |
| Disease | brain cancer (implicated_via_orthology) | 5.22e-07 | 26 | 74 | 4 | DOID:1319 (implicated_via_orthology) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 5.26e-07 | 7 | 74 | 3 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 5.26e-07 | 7 | 74 | 3 | DOID:3620 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | JAG2 ZC3H11A KMT2D CD40 REPS2 CTU1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 7.56e-07 | 525 | 74 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | JAG2 ZC3H11A KMT2D CD40 REPS2 CTU1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 7.56e-07 | 525 | 74 | 10 | C1257931 |
| Disease | Mammary Neoplasms | JAG2 ZC3H11A KMT2D CD40 REPS2 CTU1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 7.83e-07 | 527 | 74 | 10 | C1458155 |
| Disease | Breast Carcinoma | JAG2 ZC3H11A KMT2D CD40 REPS2 CTU1 NOTCH1 NOTCH2 NOTCH3 NOTCH4 | 9.43e-07 | 538 | 74 | 10 | C0678222 |
| Disease | Glioblastoma | 1.69e-06 | 79 | 74 | 5 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 2.29e-06 | 84 | 74 | 5 | C0334588 | |
| Disease | Squamous cell carcinoma of esophagus | 4.20e-06 | 95 | 74 | 5 | C0279626 | |
| Disease | Glioblastoma Multiforme | 9.01e-06 | 111 | 74 | 5 | C1621958 | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 1.86e-05 | 3 | 74 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | double outlet right ventricle (implicated_via_orthology) | 1.86e-05 | 3 | 74 | 2 | DOID:6406 (implicated_via_orthology) | |
| Disease | dextro-looped transposition of the great arteries (implicated_via_orthology) | 3.71e-05 | 4 | 74 | 2 | DOID:0060770 (implicated_via_orthology) | |
| Disease | right atrial isomerism (implicated_via_orthology) | 3.71e-05 | 4 | 74 | 2 | DOID:0060856 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 5.85e-05 | 30 | 74 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Lymphangioleiomyomatosis | 6.17e-05 | 5 | 74 | 2 | C0751674 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 6.17e-05 | 5 | 74 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | intestinal cancer (implicated_via_orthology) | 7.13e-05 | 32 | 74 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.11e-04 | 37 | 74 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | atherosclerosis (implicated_via_orthology) | 1.29e-04 | 7 | 74 | 2 | DOID:1936 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 2.10e-04 | 215 | 74 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | hemangiopericytoma (is_marker_for) | 2.21e-04 | 9 | 74 | 2 | DOID:264 (is_marker_for) | |
| Disease | Squamous cell carcinoma | 2.72e-04 | 124 | 74 | 4 | C0007137 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 2.76e-04 | 10 | 74 | 2 | EFO_0022035 | |
| Disease | Congenital Abnormality | 3.36e-04 | 11 | 74 | 2 | C0000768 | |
| Disease | response to lithium ion | 3.81e-04 | 56 | 74 | 3 | GO_0010226 | |
| Disease | visceral heterotaxy (is_implicated_in) | 4.03e-04 | 12 | 74 | 2 | DOID:0050545 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 4.32e-04 | 140 | 74 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.44e-04 | 141 | 74 | 4 | C0005684 | |
| Disease | Migraine Disorders | 4.75e-04 | 13 | 74 | 2 | C0149931 | |
| Disease | trimethylamine-N-oxide measurement | 5.54e-04 | 14 | 74 | 2 | EFO_0010541 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 6.38e-04 | 15 | 74 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 6.38e-04 | 15 | 74 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 6.38e-04 | 15 | 74 | 2 | C0154091 | |
| Disease | response to statin, LDL cholesterol change measurement | 6.38e-04 | 15 | 74 | 2 | EFO_0007804, GO_0036273 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 7.28e-04 | 16 | 74 | 2 | EFO_0020346 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 8.24e-04 | 17 | 74 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | creatinine measurement | 8.43e-04 | 995 | 74 | 9 | EFO_0004518 | |
| Disease | syndrome (implicated_via_orthology) | 9.25e-04 | 18 | 74 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Carcinoma of bladder | 9.25e-04 | 18 | 74 | 2 | C0699885 | |
| Disease | susceptibility to strep throat measurement | 9.33e-04 | 76 | 74 | 3 | EFO_0008408 | |
| Disease | FEV/FEC ratio | 9.59e-04 | 1228 | 74 | 10 | EFO_0004713 | |
| Disease | X-11470 measurement | 1.03e-03 | 19 | 74 | 2 | EFO_0021241 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.48e-03 | 195 | 74 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | chronic hepatitis B virus infection | 1.65e-03 | 24 | 74 | 2 | EFO_0004239 | |
| Disease | Cerebral Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C0750936 | |
| Disease | Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.79e-03 | 25 | 74 | 2 | C0547065 | |
| Disease | complement C4b measurement | 1.79e-03 | 25 | 74 | 2 | EFO_0008092 | |
| Disease | Pilocytic Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.79e-03 | 25 | 74 | 2 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 1.94e-03 | 26 | 74 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.94e-03 | 26 | 74 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.94e-03 | 26 | 74 | 2 | C0334582 | |
| Disease | myeloperoxidase measurement | 1.94e-03 | 26 | 74 | 2 | EFO_0005243 | |
| Disease | Anaplastic astrocytoma | 2.09e-03 | 27 | 74 | 2 | C0334579 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.25e-03 | 28 | 74 | 2 | DOID:5409 (is_implicated_in) | |
| Disease | neutrophil count | JAG2 ZBTB16 SALL1 TRIM58 ZNF516 NSD1 SNX27 TNXB NOTCH2 NOTCH4 | 2.31e-03 | 1382 | 74 | 10 | EFO_0004833 |
| Disease | gas trapping measurement | 2.41e-03 | 29 | 74 | 2 | EFO_0007628 | |
| Disease | pulmonary tuberculosis | 2.41e-03 | 29 | 74 | 2 | EFO_1000049 | |
| Disease | pulse pressure measurement | MEGF8 KDM5A ZNF516 LPXN LRP1 ZC3H11B LTBP2 SSPOP NOTCH3 NSD3 | 2.43e-03 | 1392 | 74 | 10 | EFO_0005763 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIVFVPCGHLVCAEC | 261 | Q96CA5 | |
| GTVCCCDHLTFFALL | 241 | Q86Y34 | |
| PLVHVACCCGNFFSS | 226 | P51793 | |
| TCVLGSFCVCPAHFT | 96 | P0CG36 | |
| LDEQTPGECFCRSCF | 16 | P59037 | |
| TCVLGSFCVCPAHFT | 96 | P0CG37 | |
| EEPLCTPCGHVFCAS | 26 | Q6ZMN7 | |
| GGSLLCCDSCPAAFH | 1716 | Q96L73 | |
| CLCPVGFTGSFCLHE | 1011 | Q04721 | |
| EFQCECPTGFTGHLC | 511 | P46531 | |
| CDRCLSGAYDFPHCQ | 566 | Q16787 | |
| CIDEVDAFRCFCPSG | 651 | Q9Y219 | |
| ECINFSLTCDGVPHC | 2536 | Q07954 | |
| GCSHLCFFTPHATRC | 611 | O75197 | |
| GICFLLDGHPTCDCS | 211 | Q9Y4C0 | |
| HGRCVDGIASFSCAC | 556 | Q9UM47 | |
| SCVEPDHCRCHFGFV | 2231 | Q7Z7M0 | |
| CEEEINSTFCPCGHT | 391 | Q8WY64 | |
| DTVWHPECFVCGDCF | 286 | O60711 | |
| PCQCFGHAESCDDVT | 756 | P24043 | |
| VFCQVCCDPFHPFCL | 1216 | Q9UMN6 | |
| DHCVAGCFCPEGTVL | 366 | P98088 | |
| CLAHTCFGCFKHLSP | 711 | O94886 | |
| CDGCDDSYHTFCLIP | 311 | P29375 | |
| FCFCLESGSCLHCGP | 806 | Q7Z442 | |
| PAHCCILSACSPFFT | 46 | B2RXH4 | |
| TCLNLHDSFFCICPP | 146 | O60494 | |
| CCDLEESFPVFHGLT | 3421 | Q9C0G6 | |
| CGACFCAAFEAEVLH | 26 | Q7Z7A3 | |
| CGRICTHHPGCLFFT | 226 | P03951 | |
| FEHEGACSLKSSCCP | 156 | Q5U623 | |
| ECLNSHGSFFCLCAP | 1191 | Q14767 | |
| ECVNTEGSFHCFCSP | 1541 | Q14767 | |
| ECLEGDFCFPHGECL | 881 | Q8N2S1 | |
| RTCHFCLVEDPSVGC | 26 | Q8NDX9 | |
| CNPAHADGDCFVFCI | 341 | Q92851 | |
| LIVGMCCVSPFFCHS | 21 | A0A1B0GTK4 | |
| DAHVCGRCCAEFFEL | 41 | Q9NSC2 | |
| CDSCLIHPGCTIFEN | 76 | Q6UXH9 | |
| FFHTLSGECVPCDCN | 71 | Q16363 | |
| ASAECHLCPVCGESF | 436 | Q01101 | |
| EGCLSAECSASLCFH | 121 | O75095 | |
| HRGTLCPVFDETCCF | 171 | Q8NBV8 | |
| PVTIDCGHSFCRPCF | 41 | Q8IWZ4 | |
| SEDSCTPPFEFHACG | 4421 | A2VEC9 | |
| IPCCSSTFHPEEHFC | 316 | Q9BWX1 | |
| DPDSIGAAHLIFCCF | 81 | P55000 | |
| CEATAGSPLGFICHC | 1061 | Q99466 | |
| HCPCGLVTAFVACED | 136 | Q96EM0 | |
| RDCSCPDSIFHPVCG | 446 | Q92959 | |
| ATCHTCCICGKSFPF | 31 | Q92618 | |
| LHSCLSCVFFGCFTE | 246 | Q70EK9 | |
| CLCHCQDLSSGAFPD | 36 | P55822 | |
| TGDHPYECEFCGSCF | 541 | Q05516 | |
| CDGALTLPEFCAAFH | 331 | Q8NFH8 | |
| FTCVACHPTEDCIAS | 206 | Q8IWA0 | |
| CTKGDSCPFRHCEAA | 16 | O75152 | |
| HGVFDLSRCTCSCEP | 146 | P22105 | |
| TSNAECDCTPGFHCL | 81 | Q07011 | |
| SCARCFFHSVCPAGM | 121 | P28908 | |
| CEGYNEIIFPHCACD | 421 | Q96L92 | |
| HVCCFECIDCLPGTF | 511 | Q8TE23 | |
| IFESKGFRCPQHCCS | 786 | Q9BZ95 | |
| CESCPASFHPECLSI | 926 | Q9BZ95 | |
| AEVFCRAGLCACHPD | 121 | Q6ZVL8 | |
| CTKGDSCPFRHCEAA | 16 | A0A1B0GTU1 | |
| PVTTECGHSFCLVCL | 26 | Q8N9V2 | |
| PFVCSECGKAFTHCS | 426 | O43296 | |
| PDSCCLEFSESCGLH | 166 | O14817 | |
| HPDCFVCRECFAPFS | 366 | O43294 | |
| LPFVCDDCSGIFCLE | 21 | Q8TCF1 | |
| LFHPDTCSCEDRCPF | 306 | O43915 | |
| ERLFCCLFCGSSHTP | 2801 | Q6ZQQ6 | |
| CESCVLHRSCSPGFG | 116 | P25942 | |
| CGHSFCLRCISEFCE | 31 | Q8NG06 | |
| VCEGPGELCDLFFCT | 231 | O14686 | |
| QGDSSPCSAFEFHCL | 191 | P01130 | |
| PCSAFEFHCLSGECI | 196 | P01130 |